202 related articles for article (PubMed ID: 32188801)
1. Effects of atenolol on left atrial and left ventricular function in healthy cats and in cats with hypertrophic cardiomyopathy.
Sugimoto K; Aoki T; Fujii Y
J Vet Med Sci; 2020 May; 82(5):546-552. PubMed ID: 32188801
[TBL] [Abstract][Full Text] [Related]
2. Effects of ivabradine on heart rate and left ventricular function in healthy cats and cats with hypertrophic cardiomyopathy.
Riesen SC; Schober KE; Smith DN; Otoni CC; Li X; Bonagura JD
Am J Vet Res; 2012 Feb; 73(2):202-12. PubMed ID: 22280379
[TBL] [Abstract][Full Text] [Related]
3. The effect of atenolol on NT-proBNP and troponin in asymptomatic cats with severe left ventricular hypertrophy because of hypertrophic cardiomyopathy: a pilot study.
Jung SW; Kittleson MD
J Vet Intern Med; 2011; 25(5):1044-9. PubMed ID: 21781160
[TBL] [Abstract][Full Text] [Related]
4. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of ivabradine on dynamic obstruction of the left ventricular outflow tract in cats with preclinical hypertrophic cardiomyopathy.
Blass KA; Schober KE; Li X; Scansen BA; Bonagura JD
J Vet Intern Med; 2014; 28(3):838-46. PubMed ID: 24597596
[TBL] [Abstract][Full Text] [Related]
6. Prognostic indicators in cats with hypertrophic cardiomyopathy.
Payne JR; Borgeat K; Connolly DJ; Boswood A; Dennis S; Wagner T; Menaut P; Maerz I; Evans D; Simons VE; Brodbelt DC; Luis Fuentes V
J Vet Intern Med; 2013; 27(6):1427-36. PubMed ID: 24134821
[TBL] [Abstract][Full Text] [Related]
7. Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy.
Oldach MS; Ueda Y; Ontiveros ES; Fousse SL; Visser LC; Stern JA
BMC Vet Res; 2021 Feb; 17(1):89. PubMed ID: 33622315
[TBL] [Abstract][Full Text] [Related]
8. Assessment of left atrial function in feline hypertrophic cardiomyopathy by using two- dimensional speckle tracking echocardiography.
Kiatsilapanan A; Surachetpong SD
BMC Vet Res; 2020 Sep; 16(1):344. PubMed ID: 32948164
[TBL] [Abstract][Full Text] [Related]
9. Assessment of left ventricular longitudinal function in cats with subclinical hypertrophic cardiomyopathy using tissue Doppler imaging and speckle tracking echocardiography.
Sugimoto K; Fujii Y; Sunahara H; Aoki T
J Vet Med Sci; 2015 Sep; 77(9):1101-8. PubMed ID: 25877405
[TBL] [Abstract][Full Text] [Related]
10. Effect of atenolol on heart rate, arrhythmias, blood pressure, and dynamic left ventricular outflow tract obstruction in cats with subclinical hypertrophic cardiomyopathy.
Jackson BL; Adin DB; Lehmkuhl LB
J Vet Cardiol; 2015 Dec; 17 Suppl 1():S296-305. PubMed ID: 26776587
[TBL] [Abstract][Full Text] [Related]
11. Effect of treatment with atenolol on 5-year survival in cats with preclinical (asymptomatic) hypertrophic cardiomyopathy.
Schober KE; Zientek J; Li X; Fuentes VL; Bonagura JD
J Vet Cardiol; 2013 Jun; 15(2):93-104. PubMed ID: 23684504
[TBL] [Abstract][Full Text] [Related]
12. The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy.
Kittleson MD; Côté E
J Feline Med Surg; 2021 Nov; 23(11):1028-1051. PubMed ID: 34693811
[TBL] [Abstract][Full Text] [Related]
13. Cardiac troponin I in healthy Norwegian Forest Cat, Birman and domestic shorthair cats, and in cats with hypertrophic cardiomyopathy.
Hanås S; Larsson A; Rydén J; Lilliehöök I; Häggström J; Tidholm A; Höglund K; Ljungvall I; Holst BS
J Feline Med Surg; 2022 Oct; 24(10):e370-e379. PubMed ID: 36073987
[TBL] [Abstract][Full Text] [Related]
14. Assessment of left ventricular systolic function by strain imaging echocardiography in various stages of feline hypertrophic cardiomyopathy.
Wess G; Sarkar R; Hartmann K
J Vet Intern Med; 2010; 24(6):1375-82. PubMed ID: 20738767
[TBL] [Abstract][Full Text] [Related]
15. Atenolol in cats with subclinical hypertrophic cardiomyopathy: a double-blind, placebo-controlled, randomized clinical trial of effect on quality of life, activity, and cardiac biomarkers.
Coleman AE; DeFrancesco TC; Griffiths EH; Lascelles BDX; Kleisch DJ; Atkins CE; Keene BW
J Vet Cardiol; 2020 Aug; 30():77-91. PubMed ID: 32707333
[TBL] [Abstract][Full Text] [Related]
16. Speckle tracking echocardiography in cats with preclinical hypertrophic cardiomyopathy.
Spalla I; Boswood A; Connolly DJ; Luis Fuentes V
J Vet Intern Med; 2019 May; 33(3):1232-1241. PubMed ID: 30993757
[TBL] [Abstract][Full Text] [Related]
17. Left atrial size, atrial function and left ventricular diastolic function in cats with hypertrophic cardiomyopathy.
Linney CJ; Dukes-McEwan J; Stephenson HM; López-Alvarez J; Fonfara S
J Small Anim Pract; 2014 Apr; 55(4):198-206. PubMed ID: 24506774
[TBL] [Abstract][Full Text] [Related]
18. Radiographic findings of cardiopulmonary structures can predict hypertrophic cardiomyopathy and congestive heart failure in cats.
Kim S; Lee D; Park S; Suh GH; Choi J
Am J Vet Res; 2023 Sep; 84(9):. PubMed ID: 37429568
[TBL] [Abstract][Full Text] [Related]
19. Effect of feline characteristics on plasma N-terminal-prohormone B-type natriuretic peptide concentration and comparison of a point-of-care test and an ELISA test.
Hanås S; Holst BS; Höglund K; Häggström J; Tidholm A; Ljungvall I
J Vet Intern Med; 2020 May; 34(3):1187-1197. PubMed ID: 32200578
[TBL] [Abstract][Full Text] [Related]
20. Effects of treatment with ivabradine and atenolol on reproducibility of echocardiographic indices of left heart size and function in healthy cats.
Riesen SC; Schober KE; Cervenec RM; Bonagura JD
J Vet Cardiol; 2012; 14(2):323-32. PubMed ID: 22578840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
